Simponi Works for Patients with AS, RA, and PsA – Even with Prior TNF Inhibitor Treatment
mohamed_hassan / Pixabay

Simponi Works for Patients with AS, RA, and PsA – Even with Prior TNF Inhibitor Treatment

  In some cases, people have a medical condition that doesn't respond well to treatments. The journey to finding an effective treatment can be long and difficult. But for patients…

Continue Reading Simponi Works for Patients with AS, RA, and PsA – Even with Prior TNF Inhibitor Treatment

New Lifestyle Guidelines Will Improve QOL for Patients with Rheumatic and Musculoskeletal Diseases (RMDs)

At this year's EULAR 2020 E-Congress, Dr. Suzanne Verstappen, MD, presented on how lifestyle changes could benefit patients with rheumatic and musculoskeletal diseases (RMDs). Her interest in the impact of…

Continue Reading New Lifestyle Guidelines Will Improve QOL for Patients with Rheumatic and Musculoskeletal Diseases (RMDs)
Study: Felty’s Syndrome Presents Differently in Pediatric Patients
source: pixabay.com

Study: Felty’s Syndrome Presents Differently in Pediatric Patients

According to a study published in BMC Pediatrics, the rare disease known as Felty's syndrome is primarily known to affects adults between the ages of 50 and 70, but on very rare…

Continue Reading Study: Felty’s Syndrome Presents Differently in Pediatric Patients

Despite Advancements in Precision Medicine, We Also Need to Look at Disease Broadly

Published in Social Science & Medicine, a recent study conducted by Drexel University has shed light on how, even in a world of evolving precision medicine, there is also merit in…

Continue Reading Despite Advancements in Precision Medicine, We Also Need to Look at Disease Broadly
No Adverse Reactions between Abortion and Autoimmune Rheumatic Diseases
Source: Pixabay

No Adverse Reactions between Abortion and Autoimmune Rheumatic Diseases

Is it safe for those with autoimmune rheumatic diseases to undergo the termination of a pregnancy? According to research published in Arthritis & Rheumatology, the answer is yes. Learn more…

Continue Reading No Adverse Reactions between Abortion and Autoimmune Rheumatic Diseases
Actress Tatum O’Neal Shares Her Scars from Rheumatoid Arthritis on Social Media
source: pixabay.com

Actress Tatum O’Neal Shares Her Scars from Rheumatoid Arthritis on Social Media

By Rachel Whetstone from In The Cloud Copy Although people sometimes want to hide away when a disease leaves visible marks on their bodies, Academy Award winning actress Tatum O’Neal…

Continue Reading Actress Tatum O’Neal Shares Her Scars from Rheumatoid Arthritis on Social Media
A Simple Blood Test Could Lead to Personalized Therapies for Rheumatoid Arthritis and Related Diseases
source: pixabay.com

A Simple Blood Test Could Lead to Personalized Therapies for Rheumatoid Arthritis and Related Diseases

A recent study led by Morten Aagaard Nielsen and Tue Wenzel Kragstrup, who both work at Aarhus University in Denmark, hopes to help physicians determine the best personalized treatment for…

Continue Reading A Simple Blood Test Could Lead to Personalized Therapies for Rheumatoid Arthritis and Related Diseases
A Biosimilar Drug for Treating Rheumatoid Arthritis and Ankylosing Spondylitis Begins Phase 3 Trials
source: pixabay.com

A Biosimilar Drug for Treating Rheumatoid Arthritis and Ankylosing Spondylitis Begins Phase 3 Trials

According to a story from Acrofan, the biotechnology company Clover Pharmaceuticals Inc. has recently announced that the first patient has been dosed in its phase 3 clinical study. This study…

Continue Reading A Biosimilar Drug for Treating Rheumatoid Arthritis and Ankylosing Spondylitis Begins Phase 3 Trials

A Blind Artist, A Motivational Speaker Who Can’t Talk, and a Single Mom with Rheumatoid Arthritis

  Since most people cannot truly understand the challenges faced by a blind person, then an artist who cannot see is unimaginable. According to a recent article in the British…

Continue Reading A Blind Artist, A Motivational Speaker Who Can’t Talk, and a Single Mom with Rheumatoid Arthritis
Biosimilar Drug for Ankylosing Spondylitis gets Approved by the FDA
stevepb / Pixabay

Biosimilar Drug for Ankylosing Spondylitis gets Approved by the FDA

According to a story from Ankylosing Spondylitis News, the drug Hadlima, which is a biosimilar to the drug Humira (adalimumab), was recently approved by the US Food and Drug Administration…

Continue Reading Biosimilar Drug for Ankylosing Spondylitis gets Approved by the FDA

ICYMI: A Good Business Decision vs. The Right Ethical Choice: Conducting Clinical Trials

A recent article written by Craig Klugman debates the ethical obligations pharmaceutical companies have to conduct clinical trials for drugs which have a likely potential to benefit a patient population…

Continue Reading ICYMI: A Good Business Decision vs. The Right Ethical Choice: Conducting Clinical Trials

Legal and Ethical Questions: What is Pharma’s Obligation to Pursue Development of a Promising but Non-Profitable Drug?

  Dr. Craig Klugman, a bioethics professor at DePaul University, expresses his opinion in this recent article in Columbia University’s Bioethics.com. Dr. Klugman begins with a discussion of Pfizer’s biological drug,…

Continue Reading Legal and Ethical Questions: What is Pharma’s Obligation to Pursue Development of a Promising but Non-Profitable Drug?

Researchers Discover Way to Modify Rheumatoid Arthritis Drugs to Reduce Immune Suppression

"A new way to improve the efficacy of a drug taken by millions of patients throughout the world." Background Adalimumab (also known as Humira) and infliximab (also known as Remicade)…

Continue Reading Researchers Discover Way to Modify Rheumatoid Arthritis Drugs to Reduce Immune Suppression
NIH Dishes Out Over $10 Million Towards Autoimmune Disease Therapies
source: pixabay.com

NIH Dishes Out Over $10 Million Towards Autoimmune Disease Therapies

According to a story from Scleroderma News, a team of researchers associated with Michigan Medicine has been awarded a grant to the tune of $10.2 million from the National Institutes…

Continue Reading NIH Dishes Out Over $10 Million Towards Autoimmune Disease Therapies

The FDA is Reversing Course on Unapproved Products Sold by Stem Cell Manufacturers

  The FDA’s “untitled letter” to R3 Stem Cell (R3), based in Scottsdale Arizona, cautioned R3 that the product they are marketing is considered a drug. It must, therefore, be…

Continue Reading The FDA is Reversing Course on Unapproved Products Sold by Stem Cell Manufacturers

Two Sisters with Rare Conditions Founded The Fighting H.A.R.D. Foundation to Help Other Patients Feel Less Alone

The Origins of Fighting H.A.R.D. The Fighting H.A.R.D. Foundation was established in 2015 by two sisters who both live with multiple rare diagnoses. 16-year-old Allie is diagnosed with juvenile rheumatoid…

Continue Reading Two Sisters with Rare Conditions Founded The Fighting H.A.R.D. Foundation to Help Other Patients Feel Less Alone

Extremely Positive Results from Systemic Juvenile Idiopathic Arthritis 5-year Follow-Up Study in the EU

Extremely positive results have just been announced from a 5-year follow-up study of a systemic juvenile idiopathic arthritis (sJIA) treatment called Kineret. This treatment has been approved for use in…

Continue Reading Extremely Positive Results from Systemic Juvenile Idiopathic Arthritis 5-year Follow-Up Study in the EU

How Changing to Outcome-Based Reimbursement Models is Better for Rare Disease Patients

Shifting Contracts Over the years the United States healthcare system has shifted more toward reimbursement models that are outcome-based instead of service-based. In essence, this means that instead of paying…

Continue Reading How Changing to Outcome-Based Reimbursement Models is Better for Rare Disease Patients
Can Direct-to-Consumer Genetic Testing Predict Rheumatological Diseases?
qimono / Pixabay

Can Direct-to-Consumer Genetic Testing Predict Rheumatological Diseases?

Genetic testing, such as 23andMe, has been approved by the FDA for direct-to-consumer genetic testing.  However, this type of testing has not been approved to predict rheumatic diseases. Research is…

Continue Reading Can Direct-to-Consumer Genetic Testing Predict Rheumatological Diseases?

New Potential Treatment for Systemic-Onset Juvenile Idiopathic Arthritis Investigated in China

SOJIA SOJIA stands for systemic-onset Juvenile Idiopathic Arthritis (JIV). It is a very severe form of JIA which causes joint pain, inflammation, recurrent fevers, and a skin rash. Patients often take predinsolone,…

Continue Reading New Potential Treatment for Systemic-Onset Juvenile Idiopathic Arthritis Investigated in China

Phase 3 Clinical Trial has been Initiated for Dermatomyositis

Dermatomyositis (DM) is a disease which causes muscle weakness and rashes on the skin. Immunosuppressive drugs are a common treatment prescribed for the condition. Patients may also be given methotrexate, rituximab,…

Continue Reading Phase 3 Clinical Trial has been Initiated for Dermatomyositis
Close Menu